Home > News > Genetic sequencing and blood analysis could transform medicine
April 29th, 2005
Genetic sequencing and blood analysis could transform medicine
Abstract:
In as little as 10 years, Leroy Hood, a leading expert on the human genome, predicts that everyone in the United States could have his or her DNA mapped, leading to an array of business opportunities for biotechnology and data companies. Speaking to the Washington Biotechnology and Biomedical Association's annual investment conference in Seattle on Monday, Hood talked about a revolutionary shift of using detailed blood analysis and a person's genetic sequencing to move medical diagnosis from the reactive to the predictive.
Source:
smalltimes
Bookmark:
Possible Futures
Space Solar Power: Key to a Livable Planet Earth June 10th, 2013
Global Nanotechnology Drug Delivery Market 2012-2016 June 10th, 2013
Nanorobot tetanus treatment animation June 9th, 2013
New horizons to drive the future of Medicine: European Technology Platform on Nanomedicine intends to lead the domain June 8th, 2013
Nanomedicine
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
European Technology Platform for Nanomedicine and Nanomed2020 European Consortium Launch the Nanomedicine Award June 17th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013